The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

 
Web www.patentalert.com

< STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES

> METHOD OF PRODUCING CELLULOSE CARBAMATE BLOWN FILM AND USE OF THE SAME

> PROCESS FOR THE PRODUCTION OF ESTERS OF SUGARS AND SUGAR DERIVATIVES

~ 00550